Hypertension in Advanced Chronic Kidney Disease: Saving the Kidneys or the Heart?
- 2 July 2026
- journal article
- review article
- Published by Elsevier in Advances in Kidney Disease and Health
- Vol. 33 (2) , 153-159
Abstract
No abstract availableKeywords
Funding Information
- Division of Intramural Research
This publication has 49 references indexed in Scilit:
- Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trialThe Lancet, 2023
- Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled HypertensionJAMA, 2023
- Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trialThe Lancet, 2022
- Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney DiseaseKidney International, 2021
- Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration RateJAMA Internal Medicine, 2020
- Chronic Kidney Disease and Coronary Artery DiseaseJACC, 2019
- Exclusion of Patients With Kidney Disease From Cardiovascular TrialsJAMA Internal Medicine, 2016
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in AdultsJAMA, 2014
- Hypertension Awareness, Treatment, and Control in Chronic Kidney DiseaseThe American Journal of Medicine, 2008
- Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney DiseaseResults From the AASK TrialJAMA, 2002